105 related articles for article (PubMed ID: 16311648)
21. Modulation of apoptosis signaling for cancer therapy.
Fulda S; Debatin KM
Arch Immunol Ther Exp (Warsz); 2006; 54(3):173-5. PubMed ID: 16652217
[TBL] [Abstract][Full Text] [Related]
22. Involvement of both extrinsic and intrinsic apoptotic pathways in apoptosis induced by genistein in human cervical cancer cells.
Kim SH; Kim SH; Lee SC; Song YS
Ann N Y Acad Sci; 2009 Aug; 1171():196-201. PubMed ID: 19723056
[TBL] [Abstract][Full Text] [Related]
23. The radical scavenger CR-6 protects SH-SY5Y neuroblastoma cells from oxidative stress-induced apoptosis: effect on survival pathways.
Sanvicens N; Gómez-Vicente V; Messeguer A; Cotter TG
J Neurochem; 2006 Aug; 98(3):735-47. PubMed ID: 16787420
[TBL] [Abstract][Full Text] [Related]
24. Dissecting the "end game": clinical relevance, molecular mechanisms and laboratory assessment of apoptosis.
Hung RW; Chow AW
Clin Invest Med; 2004 Dec; 27(6):324-44. PubMed ID: 15675113
[TBL] [Abstract][Full Text] [Related]
25. Cell suicide and caspases.
Rupinder SK; Gurpreet AK; Manjeet S
Vascul Pharmacol; 2007 Jun; 46(6):383-93. PubMed ID: 17382599
[TBL] [Abstract][Full Text] [Related]
26. Induction of apoptosis by epigallocatechin-3-gallate in human lymphoblastoid B cells.
Noda C; He J; Takano T; Tanaka C; Kondo T; Tohyama K; Yamamura H; Tohyama Y
Biochem Biophys Res Commun; 2007 Nov; 362(4):951-7. PubMed ID: 17803956
[TBL] [Abstract][Full Text] [Related]
27. Apoptosis and eosinophils. Regulation and clinical relevance.
Alenzi FQ
Saudi Med J; 2008 May; 29(5):643-56. PubMed ID: 18454208
[TBL] [Abstract][Full Text] [Related]
28. [Apoptosis, its mechanisms and medical significance. II. Disorders of apoptosis regulation and their relation to the development of diseases].
Novosad J; Kodydková K; Krejsek J
Vnitr Lek; 2001 Jun; 47(6):387-90. PubMed ID: 11494885
[TBL] [Abstract][Full Text] [Related]
29. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
[TBL] [Abstract][Full Text] [Related]
30. alpha-TEA inhibits survival and enhances death pathways in cisplatin sensitive and resistant human ovarian cancer cells.
Yu W; Shun MC; Anderson K; Chen H; Sanders BG; Kline K
Apoptosis; 2006 Oct; 11(10):1813-23. PubMed ID: 16850165
[TBL] [Abstract][Full Text] [Related]
31. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
32. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
Das S; Roth CP; Wasson LM; Vishwanatha JK
Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178
[TBL] [Abstract][Full Text] [Related]
33. Cholesterol level of lipid raft microdomains regulates apoptotic cell death in prostate cancer cells through EGFR-mediated Akt and ERK signal transduction.
Oh HY; Lee EJ; Yoon S; Chung BH; Cho KS; Hong SJ
Prostate; 2007 Jul; 67(10):1061-9. PubMed ID: 17469127
[TBL] [Abstract][Full Text] [Related]
34. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
[TBL] [Abstract][Full Text] [Related]
35. Regulation of p53-, Bcl-2- and caspase-dependent signaling pathway in xanthorrhizol-induced apoptosis of HepG2 hepatoma cells.
Handayani T; Sakinah S; Nallappan M; Pihie AH
Anticancer Res; 2007; 27(2):965-71. PubMed ID: 17465228
[TBL] [Abstract][Full Text] [Related]
36. Oxidative stress and left ventricular remodelling after myocardial infarction.
Hori M; Nishida K
Cardiovasc Res; 2009 Feb; 81(3):457-64. PubMed ID: 19047340
[TBL] [Abstract][Full Text] [Related]
37. Cell death targeting therapies in B lymphoid malignancies.
Saborit-Villarroya I; Roué G; López-Guerra M; Alonso R; Xargay-Torrent S; Rosich L; Colomer D
Curr Drug Targets; 2010 Jul; 11(7):769-80. PubMed ID: 20370650
[TBL] [Abstract][Full Text] [Related]
38. Apoptosis: understanding the new molecular pathway.
Jegathesan J; Liebenthal JA; Arnett MG; Clancy RL; Pierce JD
Medsurg Nurs; 2004 Dec; 13(6):371-5. PubMed ID: 15714739
[TBL] [Abstract][Full Text] [Related]
39. Apoptotic pathways as targets for therapeutic intervention.
Vucic D
Curr Cancer Drug Targets; 2008 Mar; 8(2):86. PubMed ID: 18336190
[No Abstract] [Full Text] [Related]
40. A novel silver (I) chelate: cytotoxicity and apoptotic mechanism of action on human hematopoietic malignancies.
Batarseh KI
Leukemia; 2008 Feb; 22(2):448-50. PubMed ID: 17690694
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
